| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $10K | -86.7% |
| R&D Expense | $20.1M | -29.3% |
| SG&A Expense | $19.2M | +0.7% |
| Operating Income | -$39.3M | +17.1% |
| Net Income | -$36.9M | +21.0% |
| EPS (Basic) | -$0.58 | +34.8% |
| EPS (Diluted) | -$0.58 | +34.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $41.8M | -12.7% |
| Current Assets | $43.8M | -13.7% |
| Total Assets | $45.3M | -12.5% |
| Current Liabilities | $6.8M | -23.0% |
| Total Liabilities | $6.9M | -22.3% |
| Stockholders' Equity | $38.4M | -10.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$34.9M | +24.9% |
| Capital Expenditures | $21K | -74.6% |
| Investing Cash Flow | -$21K | +74.6% |
| Financing Cash Flow | $28.8M | +593.3% |
| Free Cash Flow | -$34.9M | +25.0% |